Peptides for Pharmacies: How to Prepare for BPC-157, Category 1 Changes & What to Do Now (Webinar)

Peptides are one of the fastest-growing opportunities in pharmacy but most pharmacy owners are still asking: 👉 What should we be doing right now? In this webinar, Atrium24 and ‪@olympiapharmaceuticals‬ break down the latest peptide market updates, including potential Category 2 → Category 1 changes, and how pharmacies can prepare before peptides like BPC-157 become widely available for compounding. If you’re a pharmacy owner, pharmacist, or healthcare professional looking to understand peptides, compounding regulations, and how to grow your pharmacy in the longevity and wellness space, this is for you. 🔑 What You’ll Learn • What the latest FDA and RFK-related peptide updates mean • Category 1 vs Category 2 peptides explained • How 503B outsourcing facilities are preparing • What peptides like BPC-157, TB-500, and Ipamorelin could mean for pharmacies • How to build a longevity and wellness strategy now • What pharmacies should be doing today to prepare for demand ⏱️ Timestamps 00:00 – Welcome & webinar overview 01:15 – Atrium24 + Olympia introductions 03:15 – Why peptides are the #1 topic right now 04:00 – Major peptide update (Category 2 → Category 1 discussion) 07:00 – What this means for 503A vs 503B pharmacies 10:00 – What pharmacies are asking right now 14:00 – GLP-1 comparison & market shift 17:00 – Why peptides are different (and bigger long-term) 20:00 – Patient demand & gray market risks 25:00 – How pharmacies should prepare now 27:00 – Using data + AI (Dotti) to identify opportunities 31:00 – Olympia overview (503B operations & compliance) 36:00 – What 503Bs can compound & regulatory landscape 40:00 – BPC-157 readiness & peptide pipeline 46:00 – Key peptides on the radar (TB-500, GHK-Cu, stacks) 50:00 – Longevity pillar strategy (NAD+, glutathione, sermorelin) 57:00 – Marketing, provider outreach & patient education 1:02:00 – Clinical training & education resources 1:07:00 – How to find prescribers & grow demand 1:10:00 – Social media & compliance considerations 1:13:00 – Final takeaways & next steps 👥 Featured Speakers Nicolette Mathey – Founder & CEO, Atrium24 Anne (Annie) West – Clinical Pharmacist, Atrium24 Hayden Goldman – Director of Commercial Sales, Olympia Pharmaceuticals 🔗 Helpful Links 👉 Learn more about Atrium24: https://atrium24.io 👉 Book a strategy call / explore Dotti: https://atrium24.io/contact/ 👉 Olympia Pharmaceuticals: https://olympiapharmacy.com 👉 Watch Part 1 (Legal Webinar):    • Peptides & Pharmacy Law: What You Can (and...   📌 Who This Is For • Compounding pharmacy owners • Pharmacists exploring peptides • Healthcare providers interested in longevity medicine • Telemedicine and wellness clinics ⚠️ Disclaimer This webinar is for educational purposes only. Pharmacies should consult legal counsel, state boards, and FDA guidance before making any compounding or business decisions.